Literature DB >> 31462604

What is the Sweet Spot for Platelet Reactivity in Japanese Patients?

Masato Nakamura1.   

Abstract

Entities:  

Year:  2019        PMID： 31462604      PMCID： PMC6976722          DOI： 10.5551/jat.ED118

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  10 in total

1.  Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Authors:  Christopher P Cannon; Michael A Blazing; Robert P Giugliano; Amy McCagg; Jennifer A White; Pierre Theroux; Harald Darius; Basil S Lewis; Ton Oude Ophuis; J Wouter Jukema; Gaetano M De Ferrari; Witold Ruzyllo; Paul De Lucca; KyungAh Im; Erin A Bohula; Craig Reist; Stephen D Wiviott; Andrew M Tershakovec; Thomas A Musliner; Eugene Braunwald; Robert M Califf
Journal:  N Engl J Med       Date:  2015-06-03       Impact factor: 91.245

2.  Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).

Authors:  Rajesh Gupta; Ajay J Kirtane; M Ozgu Ozan; Bernhard Witzenbichler; Michael J Rinaldi; D Christopher Metzger; Giora Weisz; Thomas D Stuckey; Bruce R Brodie; Roxana Mehran; Ori Ben-Yehuda; Gregg W Stone
Journal:  Circ Cardiovasc Interv       Date:  2017-03       Impact factor: 6.546

3.  Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Authors:  Paul M Ridker; James Revkin; Pierre Amarenco; Robert Brunell; Madelyn Curto; Fernando Civeira; Marcus Flather; Robert J Glynn; Jean Gregoire; J Wouter Jukema; Yuri Karpov; John J P Kastelein; Wolfgang Koenig; Alberto Lorenzatti; Pravin Manga; Urszula Masiukiewicz; Michael Miller; Arend Mosterd; Jan Murin; Jose C Nicolau; Steven Nissen; Piotr Ponikowski; Raul D Santos; Pamela F Schwartz; Handrean Soran; Harvey White; R Scott Wright; Michal Vrablik; Carla Yunis; Charles L Shear; Jean-Claude Tardif
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

4.  Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Authors:  Marc S Sabatine; Robert P Giugliano; Anthony C Keech; Narimon Honarpour; Stephen D Wiviott; Sabina A Murphy; Julia F Kuder; Huei Wang; Thomas Liu; Scott M Wasserman; Peter S Sever; Terje R Pedersen
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

5.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

6.  Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.

Authors:  Gennaro Giustino; Björn Redfors; Ajay J Kirtane; Roxana Mehran; George D Dangas; Bernhard Witzenbichler; Franz-Josef Neumann; Giora Weisz; Philippe Généreux; Akiko Maehara; Thomas McAndrew; Serdar Farhan; Michael J Rinaldi; D Christopher Metzger; Timothy D Henry; David A Cox; Peter L Duffy; Ernest L Mazzaferri; Bruce R Brodie; Thomas D Stuckey; Paul Gurbel; Ori Ben-Yehuda; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2018-06-13       Impact factor: 11.195

7.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

8.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Authors:  Christopher P Cannon; Eugene Braunwald; Carolyn H McCabe; Daniel J Rader; Jean L Rouleau; Rene Belder; Steven V Joyal; Karen A Hill; Marc A Pfeffer; Allan M Skene
Journal:  N Engl J Med       Date:  2004-03-08       Impact factor: 91.245

9.  Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.

Authors:  Gregg W Stone; Bernhard Witzenbichler; Giora Weisz; Michael J Rinaldi; Franz-Josef Neumann; D Christopher Metzger; Timothy D Henry; David A Cox; Peter L Duffy; Ernest Mazzaferri; Paul A Gurbel; Ke Xu; Helen Parise; Ajay J Kirtane; Bruce R Brodie; Roxana Mehran; Thomas D Stuckey
Journal:  Lancet       Date:  2013-07-26       Impact factor: 79.321

10.  Association between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients with Coronary Artery Disease Undergoing Stent Implantation.

Authors:  Masakatsu Nishikawa; Yoshihiro Takeda; Naoei Isomura; Takashi Tanigawa; Mamoru Nanasato; Kengo Tsukahara; Kazuo Kimura; Tadateru Takayama; Atsushi Hirayama; Masafumi Kato; Hideo Nishikawa; Yuki Nishimura; Takaaki Isshiki; Hiroyoshi Yokoi
Journal:  J Atheroscler Thromb       Date:  2019-05-14       Impact factor: 4.928
  10 in total
  1 in total

1.  Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Patients with Coronary Artery Disease Treated with Clopidogrel and Prasugrel.

Authors:  Yuichi Saito; Takeshi Nishi; Shinichi Wakabayashi; Yuji Ohno; Hideki Kitahara; Noritaka Ariyoshi; Yoshio Kobayashi
Journal:  J Atheroscler Thromb       Date:  2021-07-08       Impact factor: 4.394
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.